EEG alterations during treatment with olanzapine

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 7, 2011, Pages 483-488

  Degner, Detlef ^a   Nitsche, Michael A ^a   Bias, Frank ^a   Rüther, Eckart ^a   Reulbach, Udo ^b,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Antipsychotic drugs; EEG; Olanzapine; Psychopharmacology; Schizophrenia; Seizure

Indexed keywords

OLANZAPINE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DOSE RESPONSE; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PARANOID SCHIZOPHRENIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SPIKE WAVE; YOUDEN INDEX; ADOLESCENT; BLOOD; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN WAVES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84856269661     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0208-4     Document Type: Article

References (25)

1. Jones PB, Barnes TR, Davies L et al (2006) Randomized controlled trial of the effect on quality of life of second-vs. firstgeneration antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 63:1079-1087 (Pubitemid 44498387)
2. Lieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223 (Pubitemid 41345943)
3. Leucht S, Corves C, Arbter D et al (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31-41
4. Komossa K, Rummel-Kluge C, Hunger H, et al (2009) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev CD006654
5. Haring C, Neudorfer C, Schwitzer J et al (1994) EEG alterations in patients treated with clozapine in relation to plasma levels. Psychopharmacology (Berl) 114:97-100 (Pubitemid 24150525)
6. Centorrino F, Price BH, Tuttle M et al (2002) EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 159:109-115 (Pubitemid 41070735)
7. Amann BL, Pogarell O, Mergl R et al (2003) EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641-646 (Pubitemid 38028791)
8. Freudenreich O, Weiner RD, McEvoy JP (1997) Clozapineinduced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry 42:132-137 (Pubitemid 27276076)
9. Gross A, Joutsiniemi SL, Rimon R, Appelberg B (2004) Clozapineinduced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry 37:119-122 (Pubitemid 38680332)
10. Silvestri RC, Bromfield EB, Khoshbin S (1998) Clozapineinduced seizures and EEG abnormalities in ambulatory psychiatric patients. Ann Pharmacother 32:1147-1151 (Pubitemid 28543458)
11. Welch J, Manschreck T, Redmond D (1994) Clozapine-induced seizures and EEG changes. J Neuropsychiatry Clin Neurosci 6:250-256 (Pubitemid 24239741)
12. Beasley CM Jr, Tollefson GD, Tran PV (1997) Safety of olanzapine. J Clin Psychiatry 58(Suppl 10):13-17 (Pubitemid 27333175)
13. Fink M (2002) EEG changes with antipsychotic drugs. Am J Psychiatry 159:1439 (discussion 1439)
14. Jasper H (1958) Progress and problems in brain research. J Mt Sinai Hosp NY 25:244-253
15. Schuld A, Kuhn M, Haack M et al (2000) A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 33:109-111 (Pubitemid 30346139)
16. Hubl D, Kleinlogel H, Frolich L et al (2001) Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine. Psychopharmacology (Berl) 158:281-288 (Pubitemid 33071166)
17. Yamada K, Isotani T, Irisawa S et al (2004) EEG Global field power spectrum changes after a single dose of atypical antipsychotics in healthy volunteers. Brain Topogr 16:281-285 (Pubitemid 38988011)
18. Pillmann F, Schlote K, Broich K, Marneros A (2000) Electroencephalogram alterations during treatment with olanzapine. Psychopharmacology (Berl) 150:216-219 (Pubitemid 30429302)
19. Nitsche MA, Monte-Silva K, Kuo MF, Paulus W (2010) Dopaminergic impact on cortical excitability in humans. Rev Neurosci 21:289-298
20. Wichniak A, Szafranski T, Wierzbicka A, Waliniowska E, Jernajczyk W (2006) Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment. J Psychopharmacol 20:80-85
21. Wyderski RJ, Starrett WG, Abou-Saif A (1999) Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 33:787-789 (Pubitemid 29387654)
22. Fountain NB, Freeman JM (2006) EEG is an essential clinical tool: pro and con. Epilepsia 47(Suppl 1):23-25 (Pubitemid 44527130)
23. Kim HL, Donnelly JH, Tournay AE, Book TM, Filipek P (2006) Absence of seizures despite high prevalence of epileptiform EEG abnormalities in children with autism monitored in a tertiary care center. Epilepsia 47:394-398
24. Gschwandtner U, Pflueger MO, Semenin V et al (2009) EEG: a helpful tool in the prediction of psychosis. Eur Arch Psychiatry Clin Neurosci 259:257-262
25. Brocheler A, Bergmann F, Schneider F (2009) Models of mental health care in psychiatry across sectoral borders. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):S227-S232